Headlines

Motley Rice member and medical lawyer Kimberly Barone Baden will speak at the Zoloft and Birth Defects Litigation Conference presented by HB Litigation Conferences on Wednesday, July 11, 2012.

In a recent newsletter to alumni, the University of South Carolina Darla Moore School of Business profiled Motley Rice co-founder Joe Rice, highlighting his diverse legal practice and numerous business accomplishments.

Motley Rice securities fraud litigator Rebecca Katz will attend the 28th Annual Florida Public Pension Trustees Association (FPPTA) conference being held from Sunday, June 24 to Wednesday, June 27.

Motley Rice members Nate Finch and Vin Greene will serve as guest speakers at the upcoming HB Litigation Conference, "Northeast Asbestos Litigators and Judges Forum."

Securities lawyers Marlon Kimpson and Badge Humphries have been invited to attend the 23rd Annual National Association of Securities Professionals (NASP) Pension and Financial Services Conference.

This spring, the CIA thwarted a terrorist attempt allegedly crafted by al Qaeda to smuggle a bomb aboard a civilian aircraft bound for the U.S.

Motley Rice member Nate Finch and human rights lawyer Elizabeth Smith will attend the American Constitution Society's (ACS) Annual Convention, "Democracy at Stake."

The 9/11 Families United to Bankrupt Terrorism, more than 6,600 survivors and family members of those killed in the Sept. 11, 2001, terrorist attacks, issued an announcement applauding the introduction of The Justice Against Sponsors of Terrorism Act (JASTA) in the U.S. House of Representatives.

Earlier this week, the Transportation Security Administration (TSA) fired five and suspended 38 employees after an investigation found they had failed to execute random screenings last year at the Southwest Florida International Airport in Fort Myers, Fla.

On June 4, 2012, the judges overseeing the pelvic mesh multidistrict litigation in the U.S. District Court for the Southern District of West Virginia were notified that Johnson & Johnson subsidiary and pelvic mesh manufacturer Ethicon, Inc., advised the FDA of its plans to recall four of its transvaginal/pelvic mesh and sling devices from the U.S. market.